P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax

PA Warn; A Parmar; A Sharp; M Heep; J Spickermann; DW Denning

doi:10.1016/S0924-8579(07)71789-2

P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax

PA Warn, A Parmar, A Sharp, M Heep, J Spickermann, DW Denning

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S560-S560
Journal	International Journal of Antimicrobial Agents
Volume	29
DOIs	https://doi.org/10.1016/S0924-8579(07)71789-2
Publication status	Published - 2007

Access to Document

10.1016/S0924-8579(07)71789-2

Cite this

Warn, PA., Parmar, A., Sharp, A., Heep, M., Spickermann, J., & Denning, DW. (2007). P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax. International Journal of Antimicrobial Agents, 29, S560-S560. https://doi.org/10.1016/S0924-8579(07)71789-2

Warn, PA ; Parmar, A ; Sharp, A et al. / P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax. In: International Journal of Antimicrobial Agents. 2007 ; Vol. 29. pp. S560-S560.

@article{b3fc6fa4bdff45238c84566cdfd6bdc6,

title = "P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax",

author = "PA Warn and A Parmar and A Sharp and M Heep and J Spickermann and DW Denning",

year = "2007",

doi = "10.1016/S0924-8579(07)71789-2",

language = "English",

volume = "29",

pages = "S560--S560",

journal = "International Journal of Antimicrobial Agents",

issn = "1872-7913",

publisher = "Elsevier BV",

}

Warn, PA, Parmar, A, Sharp, A, Heep, M, Spickermann, J & Denning, DW 2007, 'P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax', International Journal of Antimicrobial Agents, vol. 29, pp. S560-S560. https://doi.org/10.1016/S0924-8579(07)71789-2

P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax. / Warn, PA; Parmar, A; Sharp, A et al.
In: International Journal of Antimicrobial Agents, Vol. 29, 2007, p. S560-S560.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax

AU - Warn, PA

AU - Parmar, A

AU - Sharp, A

AU - Heep, M

AU - Spickermann, J

AU - Denning, DW

PY - 2007

Y1 - 2007

U2 - 10.1016/S0924-8579(07)71789-2

DO - 10.1016/S0924-8579(07)71789-2

M3 - Article

SN - 1872-7913

VL - 29

SP - S560-S560

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

ER -

Warn PA, Parmar A, Sharp A, Heep M, Spickermann J, Denning DW. P1950 In vivo efficacy of the triazole BAL8557 against disseminated Candida albicans in mice assessed by survival and tissue bur-den in temporarily and persistently neutropenic mice treated with 1-7 doses of drug over a dose range of 20-80\% of Emax. International Journal of Antimicrobial Agents. 2007;29:S560-S560. doi: 10.1016/S0924-8579(07)71789-2